Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL

Blood (2010) 116 (23): 4916–4925.

https://doi.org/10.1182/blood-2010-03-276766

Published: 2010

Journal Articles

A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36

Tiemo Katzenberger, Jörg Kalla, Ellen Leich, Heike Stöcklein, Elena Hartmann, Sandra Barnickel, Swen Wessendorf, M. Michaela Ott, Hans Konrad Müller-Hermelink, Andreas Rosenwald, German Ott

Blood (2009) 113 (5): 1053–1061.

https://doi.org/10.1182/blood-2008-07-168682

Published: 2009

Journal Articles

Molecular Signatures Implicate Innate Immune Cells, Fibrosis, and Angiogenesis in Survival Following R-CHOP Treatment of Diffuse Large B Cell Lymphoma

Blood (2008) 112 (11): 475.

https://doi.org/10.1182/blood.V112.11.475.475

Published: 2008

Journal Articles

Combined functional and molecular analysis of tumor cell signaling defines 2 distinct myeloma subgroups: Akt-dependent and Akt-independent multiple myeloma

Angela Zöllinger, Thorsten Stühmer, Manik Chatterjee, Stefan Gattenlöhner, Eugenia Haralambieva, Hans-Konrad Müller-Hermelink, Mindaugas Andrulis, Axel Greiner, Carmen Wesemeier, Jörg C. Rath, Hermann Einsele, Ralf C. Bargou

Blood (2008) 112 (8): 3403–3411.

https://doi.org/10.1182/blood-2007-11-119362

Published: 2008

Includes: Supplemental data

Journal Articles

Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy.

Georg Lenz, MD, George Wright, PhD, Sandeep Dave, MD, Alexander Kohlmann, PhD, Wenming Xiao, PhD, John Powell, MS, Hong Zhao, Weihong Xu, Randy D. Gascoyne, MD, Joseph M. Connors, MD, Lorraine May, MD, Dennis D. Weisenburger, MD, Tim Greiner, MD, Julie Vose, MD, James O. Armitage, MD, Javeed Iqbal, MD, Martin Bast, MD, Kai Fu, MD, Elias Campo, MD, Emili Montserrat, MD, Armando Lopez-Guillermo, MD, Pedro Jares, MD, Antonio Martinez, MD, Betty Gibbs, MD, Lisa M. Rimsza, MD, Richard I. Fisher, MD, Rita M. Braziel, MD, Ray Tubbs, MD, James Cook, MD, Brad Pohlman, MD, John Sweetenham, MD, Gunhild Troen, MD, Erlend B. Smeland, MD, Jan Delabie, MD, Stein Kvaloy, MD, Harald Holte, MD, Elaine S. Jaffe, MD, Wyndham H. Wilson, MD, Nicole Grant, MD, Elena Hartmann, MD, Andreas Rosenwald, MD, German Ott, MD, Hans-Konrad Muller-Hermelink, MD, T. Andrew Lister, MD, Mickey Williams, PhD, Lothar Wieczorek, PhD, Wing C. Chan, MD, Louis M. Staudt, MD, PhD

Blood (2007) 110 (11): 348.

https://doi.org/10.1182/blood.V110.11.348.348

Published: 2007

Journal Articles

Distinct Genetic Aberrations in Molecular Subtypes of Diffuse Large B Cell Lymphoma Detected by Array CGH.

Georg Lenz, MD, George W. Wright, PhD, Sandeep Dave, MD, Wenming Xiao, PhD, John Powell, MS, Andreas Rosenwald, MD, Hans-Konrad Muller-Hermelink, MD, Randy D. Gascoyne, MD, Joseph M. Connors, MD, Elias Campo, MD, Elaine S. Jaffe, MD, Jan Delabie, MD, Erlend B. Smeland, MD, Lisa Rimsza, MD, Richard I. Fisher, MD, Wing C. Chan, MD, Louis M. Staudt, MD

Blood (2007) 110 (11): 2631.

https://doi.org/10.1182/blood.V110.11.2631.2631

Published: 2007

Journal Articles

SNP Array Analysis Reveals Copy Number Alterations and Uniparental Disomy in Mantle Cell Lymphomas at High Resolution.

Elena M. Hartmann, MD, Itziar Salaverria, Silvia Bea, PhD, Andreas Zettl, MD, Pedro Jares, PhD, Francesc Bosch, MD, PhD, German Ott, MD, Hans Konrad Muller-Hermelink, MD, Andreas Rosenwald, MD, Elias Campo, MD

Blood (2007) 110 (11): 1585.

https://doi.org/10.1182/blood.V110.11.1585.1585

Published: 2007

Journal Articles

CARD11 as an Oncogene in Diffuse Large B Cell Lymphoma.

Blood (2007) 110 (11): 692.

https://doi.org/10.1182/blood.V110.11.692.692

Published: 2007

Journal Articles

Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expression

Stefan Gattenloehner, Sergei Chuvpilo, Claudia Langebrake, Dirk Reinhardt, Hans-Konrad Müller-Hermelink, Edgar Serfling, Angela Vincent, Alexander Marx

Blood (2007) 110 (6): 2027–2033.

https://doi.org/10.1182/blood-2007-02-074203

Published: 2007

Includes: Supplemental data

Journal Articles

Aberrant Immunoglobulin Class Switch Recombination and Switch Translocations in Activated B Cell-Like Diffuse Large B-Cell Lymphoma.

Georg Lenz, MD, Inga Nagel, PhD, Reiner Siebert, MD, Warren Sanger, MD, George W. Wright, PhD, Hong Zhao, Andreas Rosenwald, MD, Hans-Konrad Muller-Hermelink, MD, Randy D. Gascoyne, MD, Elias Campo, MD, Elaine S. Jaffe, MD, Erlend B. Smeland, MD, Richard I. Fisher, MD, W. Michael Kuehl, MD, Wing C. Chan, MD, Louis M. Staudt, MD, PhD

Blood (2006) 108 (11): 356.

https://doi.org/10.1182/blood.V108.11.356.356

Published: 2006

Journal Articles

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

Blood (2005) 106 (9): 3183–3190.

https://doi.org/10.1182/blood-2005-04-1399

Published: 2005

Includes: Supplemental data

Journal Articles

The serine protease granzyme M is preferentially expressed in NK-cell, γδ T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity

Laszlo Krenacs, Mark J. Smyth, Eniko Bagdi, Tibor Krenacs, Laszlo Kopper, Thomas Rudiger, Andreas Zettl, Hans Konrad Muller-Hermelink, Elaine S. Jaffe, Mark Raffeld

Blood (2003) 101 (9): 3590–3593.

https://doi.org/10.1182/blood-2002-09-2908

Published: 2003

Journal Articles

Burkitt’s Lymphoma: A Single Disease With Multiple Variants

Elaine S. Jaffe, Jacques Diebold, Nancy L. Harris, Hans-Konrad Muller-Hermelink, Georges Flandrin, James W. Vardiman

Blood (1999) 93 (3): 1124.

https://doi.org/10.1182/blood.V93.3.1124

Published: 1999

NARROW

Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL

A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36

Molecular Signatures Implicate Innate Immune Cells, Fibrosis, and Angiogenesis in Survival Following R-CHOP Treatment of Diffuse Large B Cell Lymphoma

Combined functional and molecular analysis of tumor cell signaling defines 2 distinct myeloma subgroups: Akt-dependent and Akt-independent multiple myeloma

Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy.

Distinct Genetic Aberrations in Molecular Subtypes of Diffuse Large B Cell Lymphoma Detected by Array CGH.

SNP Array Analysis Reveals Copy Number Alterations and Uniparental Disomy in Mantle Cell Lymphomas at High Resolution.

CARD11 as an Oncogene in Diffuse Large B Cell Lymphoma.

Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expression

Aberrant Immunoglobulin Class Switch Recombination and Switch Translocations in Activated B Cell-Like Diffuse Large B-Cell Lymphoma.

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

The serine protease granzyme M is preferentially expressed in NK-cell, γδ T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity

Burkitt’s Lymphoma: A Single Disease With Multiple Variants

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only